- Home
- EKSO vs PTIX Comparison
EKSO vs PTIX Comparison
Compare EKSO & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EKSO
- PTIX
- Stock Information
- Founded
- EKSO 2005
- PTIX 1994
- Country
- EKSO United States
- PTIX United States
- Employees
- EKSO N/A
- PTIX N/A
- Industry
- EKSO Medical/Dental Instruments
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- EKSO Health Care
- PTIX Health Care
- Exchange
- EKSO Nasdaq
- PTIX Nasdaq
- Market Cap
- EKSO 7.7M
- PTIX 6.3M
- IPO Year
- EKSO N/A
- PTIX 2016
- Fundamental
- Price
- EKSO $4.95
- PTIX $2.58
- Analyst Decision
- EKSO Strong Buy
- PTIX
- Analyst Count
- EKSO 2
- PTIX 0
- Target Price
- EKSO $34.75
- PTIX N/A
- AVG Volume (30 Days)
- EKSO 47.1K
- PTIX 73.0K
- Earning Date
- EKSO 10-28-2025
- PTIX 11-13-2025
- Dividend Yield
- EKSO N/A
- PTIX N/A
- EPS Growth
- EKSO N/A
- PTIX N/A
- EPS
- EKSO N/A
- PTIX N/A
- Revenue
- EKSO $14,749,000.00
- PTIX N/A
- Revenue This Year
- EKSO N/A
- PTIX N/A
- Revenue Next Year
- EKSO $49.96
- PTIX N/A
- P/E Ratio
- EKSO N/A
- PTIX N/A
- Revenue Growth
- EKSO N/A
- PTIX N/A
- 52 Week Low
- EKSO $2.73
- PTIX $2.25
- 52 Week High
- EKSO $15.45
- PTIX $15.26
- Technical
- Relative Strength Index (RSI)
- EKSO 54.44
- PTIX 32.36
- Support Level
- EKSO $4.61
- PTIX $2.85
- Resistance Level
- EKSO $5.44
- PTIX $3.19
- Average True Range (ATR)
- EKSO 0.38
- PTIX 0.22
- MACD
- EKSO -0.03
- PTIX -0.05
- Stochastic Oscillator
- EKSO 59.49
- PTIX 0.98
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.